Mastery EAQ Ch. 22

A  Monitor the patient for a toxic reaction to the drug.

B  Administer a decreased dose of the medication.

C  Administer an increased dose of the medication.

D  Notify the health care provider of this information.

A  A patient with a heart rate of 90 beats/min

B  A patient with a potassium level of 3.4 mEq/L

C  A patient with an elevated creatinine level

D  A patient with constipation

A  “Sit on the side of the bed before getting up, and get up slowly.”

B  “Do not take the medication with food.”

C  “Only take this medication in the morning.”

D  “Take the medication with potassium supplements.”

A  Tachycardia

B  Angina pectoris

C  Hypotension

D  Subarachnoid hemorrhage

A  Monitor blood pressure continuously.

B  Administer with a full glass of water.

C  Make certain the patient does not crush the pill.

D  Measure hourly output.

A  Serum potassium of 3.8 mEq/L

B  Serum sodium of 140 mEq/L

C  Cool, dry, pale extremities

D  Blood pressure of 120/72 mm Hg

A  “If I have trouble sleeping, I should call the health care provider.”

B  “I cannot go out in the sun while on this therapy.”

C  “I should stop the drug if I have ringing in my ears.”

D  “If I develop a chronic cough, I should notify my health care provider.”

A  “You will see the capsule shell in your stool, but don’t worry, the drug has been absorbed.”

B  “You will get a headache the first time you take this medication.”

C  “Nausea and vomiting are common but can be helped by eating crackers.”

D  “Some people get a feeling of chills for a few hours after the first dose.”

A  Docusate sodium

B  Aspirin

C  Spironolactone

D  Morphine sulfate

A  “A glass of wine a few times a week should not be a problem.”
“You may develop a nonproductive, dry cough from this medication.”

B  “You may develop a nonproductive, dry cough from this medication.”
“The medication is contraindicated if you develop benign prostatic hypertrophy (BPH).”

C  “Do not be concerned if you see the matrix of the capsule in your stool.”
“Be especially careful when changing position after your first dose of the medication.”

D  “The medication is contraindicated if you develop benign prostatic hypertrophy (BPH).”
“A glass of wine a few times a week should not be a problem.”

A  Ibuprofen can potentiate the effect of losartan.

B  Ibuprofen can lead to potential renal failure.

C  The risk for the side effect of cough is increased.

D  Ibuprofen increases the risk for hypokalemia.

A  Warfarin, Ibuprofen, Alprazolam

B  Warfarin, Alprazolam, Potassium chloride

C  Spironolactone, Warfarin, Alprazolam

D  Spironolactone, Ibuprofen, Potassium chloride

A  Lisinopril, Eplerenone

B  Valsartan, Lisinopril

C  Diazoxide, Hydralazine

D  Aliskiren, Valsartan

A  Instruct the patient to weigh daily.

B  Collaborate with the health care provider to find a combination ACE inhibitor and diuretic.

C  Instruct the patient to reduce dietary sodium.

D  Ask the patient to perform a 24-hour dietary recall.

A  “Angiotensin II is a potent vasodilator.”
“They promote sodium and water retention.”

B  “They reduce afterload.”
“Systemic vascular resistance (SVR) is decreased.”

C  “They promote sodium and water retention.”
“ACE inhibitors modify the function of the sympathetic nervous system (SNS).”

D  “ACE inhibitors modify the function of the sympathetic nervous system (SNS).”
“Angiotensin II is a potent vasodilator.”

A  Administer potassium chloride intravenously.

B  Insert a Foley catheter.

C  Send the patient for hemodialysis.

D  Administer aspirin.

A  Treprostinil

B  Sodium nitroprusside

C  Bosentan

D  Eplerenone

A  Peripheral pulses

B  Serum potassium

C  Breath sounds

D  Mental status

A  Potassium supplements

B  Intravenous fluids

C  Antianxiety medication

D  Calcium chloride

A  Hemoglobin and hematocrit levels

B  Serum cyanide level

C  12-Lead electrocardiogram (ECG)

D  Fasting blood glucose level

A  Restrict dietary fiber intake. Inform the patient that this is a common side effect of the medication. Limit fluids to 1000 mL/day.

B  Discuss incorporation of psyllium-based products in the plan of care with the health care provider. Restrict dietary fiber intake. Limit fluids to 1000 mL/day.

C  Restrict dietary fiber intake. Limit fluids to 1000 mL/day. Increase the amount of fruits and vegetables in the diet.

D  Increase the amount of fruits and vegetables in the diet. Inform the patient that this is a common side effect of the medication. Discuss incorporation of psyllium-based products in the plan of care with the health care provider.

A  Decreased level of lithium

B  Toxic level of lithium

C  Toxic level of the ACE inhibitor

D  Decreased level of the ACE inhibitor

A  Enalapril

B  Ramipril

C  Losartan

D  Captopril

A  “I will not mow my lawn until I see how this medication makes me feel.”

B  “I will include rest periods during the day to help me tolerate the fatigue my medicine may cause.”

C  “I will change my position slowly to prevent feeling dizzy.”

D  “I will check my blood pressure daily and take my medication when it is over 140/90 mm Hg.”

A  Hold the medication.

B  Weigh the patient.

C  Determine the patient’s history.

D  Call the health care provider.

A  Persistent dry mouth

B  Serum sodium of 147 mEq/L

C  A dry, hacking cough

D  Serum potassium of 4.2 mEq/L

A  Candesartan

B  Propranolol

C  Felodipine

D  Hydrochlorothiazide

A  15.0 mg/day

B  10.5 mg/day

C  16.5 mg/day

D  12.5 mg/day

A  Diabetes, Emphysema, Stroke

B  Heart failure, Diabetes, Emphysema

C  Stroke, Heart failure, Cardiovascular disease

D  Cardiovascular disease, Diabetes, Emphysema

A  Furosemide

B  Hydralazine

C  Doxazosin

D  Enalapril

A  Angioedema

B  Fatigue

C  Diarrhea

D  Dry, nonproductive cough

A  Calcium level of 8 mEq/dL

B  Blood pressure of 80/60 mm Hg

C  Potassium level of 5 mEq/dL

D  Apical pulse of 100 beats/min

A  Constipation, Difficulty ambulating to the bathroom, Dizziness,

B  Dizziness, Headache, Vomiting and diarrhea

C  Vomiting and diarrhea, Difficulty ambulating to the bathroom, Disorientation to person, place, and time

D  Constipation, Difficulty ambulating to the bathroom, Disorientation to person, place, and time

A  Instruct the patient to take antitussive medication until the symptoms subside.

B  Consult with the health care provider to switch the medication.

C  Tell the patient that the cough will subside in a few days.

D  Assess the patient for other symptoms of upper respiratory infection.

A  Sodium nitroprusside

B  Treprostinil

C  Eplerenone

D  Losartan

A  Temperature of 38°C (100.4°F)

B  Blood pressure of 110/70 mm Hg

C  Heart rate of 40 beats/min

D  Respiratory rate of 20 breaths/min

A  Increased urinary output

B  Decreased cardiac output

C  Tachypnea

D  Tachycardia

A  “This medication will vasodilate your blood vessels to lower your blood pressure.”

B  “This medication will help your body to get rid of sodium.”

C  “This medication will help you to lose weight to lower your blood pressure.”

D  “This medication will work to cause your body to get rid of fluid.”

A  Loop

B  Thiazide

C  Potassium-sparing

D  Osmotic

A  Orthostatic blood pressure assessment

B  Teaching about potential tachycardia

C  Respiratory assessment

D  Assessment of blood glucose levels

A  “Remove the old patch before applying the new patch.”

B  “Stay in bed for at least an hour after receiving a new patch.”

C  “Take the medication on an empty stomach.”

D  “Keep the new patch on for 30 minutes before removing the old patch.”

A  Anorexia

B  Vomiting

C  Rash

D  Syncope

A  Take the radial pulse for 1 full minute before administering the drug.

B  Encourage intake of foods rich in potassium.

C  Monitor serum calcium and sodium levels daily.

D  Schedule the dose to be taken in the evening.

A  Enalapril

B  Valsartan

C  Metoprolol

D  Furosemide

A  Increased effect of the angiotensin II receptor blocker drug

B  Decreased effect of the rifampin

C  Decreased effect of the angiotensin II receptor–blocker drug

D  Increased effect of the rifampin

A  Increased effect of the nonsteroidal anti-inflammatory drug

B  Decreased effect of the angiotensin II receptor–blocker drug

C  Increased effect of the angiotensin II receptor–blocker drug

D  Decreased effect of the nonsteroidal anti-inflammatory drug

A  “CCBs promote excretion of water.”

B  “CCBs increase blood return to heart.”

C  “CCBs block reabsorption of sodium.”

D  “CCBs relax vascular smooth muscle.”

A  “Don’t worry. Eventually, tolerance will develop.”

B  “Sexual dysfunction happens with this therapy, and you will learn to accept it.”

C  “The health care provider can work with you on changing the dose or medication.”

D  “This is an unusual occurrence, but it is important to stay on your medication.”

A  Epoprostenol

B  Ambrisentan

C  Treprostinil

D  Sildenafil

A  Decrease in platelet aggregation

B  Hypotension

C  Rash

D  Bradycardia

A  Carvedilol

B  Clonidine

C  Nebivolol

D  Doxazosin

A  Prazosin (Minipress)

B  Terazosin (Hytrin)

C  Tamsulosin (Flomax)

D  Doxazosin (Cardura)

A  Soft drinks

B  Alcohol

C  Laxative

D  Milk

A  Clonidine

B  Terazosin

C  Carvedilol

D  Doxazosin

A  Phenylalkylamines

B  Aliskiren

C  Benzothiazepines

D  Dihydropyridines

A  Promoting cardiovascular health

B  Reducing renal morbidity and mortality

C  Increasing life span of population

D  Reducing heart failure

A  “This type of hypertension has a definitive cause.”

B  “This type of hypertension is not treatable.”

C  “The cause of your hypertension is unknown but treatable.”

D  “Once you have surgery, this will go away.”

A  Diastolic blood pressure of 80 mm Hg after exercise

B  Diastolic pressure of 70 mm Hg

C  Systolic pressure consistently above 140 mm Hg

D  Blood pressure of 140/90 mm Hg after walking up two flights of stairs

A  Perform a neurologic assessment. Assess oxygenation and ventilation. Draw baseline serum electrolyte levels. Assess the patient for peripheral edema.

B  Evaluate the electrocardiogram. Perform a neurologic assessment. Assess oxygenation and ventilation. Obtain an intravenous infusion pump.

C  Assess oxygenation and ventilation. Obtain an intravenous infusion pump. Draw baseline serum electrolyte levels. Assess the patient for peripheral edema.

D  Draw baseline serum electrolyte levels. Evaluate the electrocardiogram. Perform a neurologic assessment. Assess the patient for peripheral edema.

A  A patient who has stopped taking a beta blocker because of cost

B  A patient who is on a beta blocker and a thiazide diuretic

C  A patient who has been on beta blockers for 1 day

D  A patient who is taking a beta blocker and furosemide

A  Upper arm

B  Forearm

C  Upper thigh

D  Lower leg